Clinical Trial Update: Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks

View source ↗

Summary

This clinical trial is recruiting glioma patients with IDH-mutant and IDH-wildtype status to study cognitive changes after chemoradiotherapy, including radiatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Glioma | Status: RECRUITING